JPMorgan Chase & Co’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$470 Sell
771
-399
-34% -$243 ﹤0.01% 5814
2025
Q1
$883 Sell
1,170
-149,315
-99% -$113K ﹤0.01% 5764
2024
Q4
$145K Buy
150,485
+70,132
+87% +$67.5K ﹤0.01% 4647
2024
Q3
$116K Buy
80,353
+79,582
+10,322% +$115K ﹤0.01% 4668
2024
Q2
$933 Sell
771
-58,472
-99% -$70.8K ﹤0.01% 5605
2024
Q1
$139K Buy
59,243
+39,413
+199% +$92.6K ﹤0.01% 4606
2023
Q4
$37.5K Sell
19,830
-8,146
-29% -$15.4K ﹤0.01% 5095
2023
Q3
$38.3K Buy
27,976
+2,166
+8% +$2.97K ﹤0.01% 4980
2023
Q2
$62.7K Buy
25,810
+2,482
+11% +$6.03K ﹤0.01% 4806
2023
Q1
$134K Buy
23,328
+5,516
+31% +$31.7K ﹤0.01% 4518
2022
Q4
$159K Sell
17,812
-538
-3% -$4.8K ﹤0.01% 4306
2022
Q3
$261K Buy
18,350
+1,407
+8% +$20K ﹤0.01% 4052
2022
Q2
$247K Buy
16,943
+177
+1% +$2.58K ﹤0.01% 4216
2022
Q1
$335K Buy
16,766
+2,564
+18% +$51.2K ﹤0.01% 4199
2021
Q4
$247K Buy
14,202
+2,450
+21% +$42.6K ﹤0.01% 4422
2021
Q3
$93K Buy
11,752
+2,236
+23% +$17.7K ﹤0.01% 4745
2021
Q2
$98K Buy
+9,516
New +$98K ﹤0.01% 4775
2021
Q1
Sell
-381
Closed -$5K 5228
2020
Q4
$5K Buy
381
+378
+12,600% +$4.96K ﹤0.01% 4716
2020
Q3
$0 Hold
3
﹤0.01% 4759
2020
Q2
$0 Sell
3
-8,976
-100% ﹤0.01% 4696
2020
Q1
$65K Sell
8,979
-856
-9% -$6.2K ﹤0.01% 4063
2019
Q4
$103K Sell
9,835
-899
-8% -$9.42K ﹤0.01% 4009
2019
Q3
$665K Buy
10,734
+511
+5% +$31.7K ﹤0.01% 3240
2019
Q2
$734K Sell
10,223
-438
-4% -$31.4K ﹤0.01% 3195
2019
Q1
$510K Sell
10,661
-709
-6% -$33.9K ﹤0.01% 3368
2018
Q4
$686K Sell
11,370
-706
-6% -$42.6K ﹤0.01% 3229
2018
Q3
$1.28M Sell
12,076
-10,711
-47% -$1.14M ﹤0.01% 3021
2018
Q2
$1.46M Sell
22,787
-1,045
-4% -$67K ﹤0.01% 2968
2018
Q1
$1.6M Buy
+23,832
New +$1.6M ﹤0.01% 2859